LIVER DISEASES
Clinical trials for LIVER DISEASES explained in plain language.
Never miss a new study
Get alerted when new LIVER DISEASES trials appear
Sign up with your email to follow new studies for LIVER DISEASES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo targets liver vein pressure in cirrhosis patients
Disease control TerminatedThis study tested whether a medicine called Avenciguat (BI 685509), taken alone or with empagliflozin, could lower high blood pressure in the liver's main vein in adults with cirrhosis. About 90 people with cirrhosis from hepatitis or fatty liver disease were expected to join. Th…
Matched conditions: LIVER DISEASES
Phase: PHASE2 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
Blood test holds promise for early liver cancer detection
Diagnosis TerminatedThis study looked at whether tiny bits of genetic material (extracellular RNA) found in the blood can help doctors diagnose liver cancer or other liver diseases. Researchers planned to enroll about 1,865 people with liver cancer, bile duct cancer, cirrhosis, or chronic liver dise…
Matched conditions: LIVER DISEASES
Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated May 11, 2026 20:52 UTC
-
Researchers track hepatitis b patients to learn how treatments work in real life
Knowledge-focused TerminatedThis study looked at over 1,700 adults with chronic hepatitis B in the US and Canada to understand how the disease progresses and how treatments are used in routine care. Researchers collected data from medical records, not by giving any new treatment. The goal was to learn more …
Matched conditions: LIVER DISEASES
Sponsor: Target PharmaSolutions, Inc. • Aim: Knowledge-focused
Last updated May 12, 2026 13:41 UTC